by TractManager | Sep 30, 2021 | Emerging Technology Report
Livmarli (maralixibat) is an ileal bile acid transporter (IBAT) inhibitor indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 1 year of age and older. If you have a Hayes login, click here to view the full report on the...
by TractManager | Sep 30, 2021 | Emerging Technology Report
The OCS Liver is a portable extracorporeal liver perfusion and monitoring system indicated for the preservation and monitoring of hemodynamics and metabolic function, which allows for ex-vivo assessment of liver allografts from donor-after-brain-death (DBD) and...
by TractManager | Sep 27, 2021 | Health Technology Assessment
Focus of the Report: This health technology assessment focuses on the use of an absorbable perirectal spacer (APS) (SpaceOAR; Boston Scientific) to prevent rectal toxicity in patients undergoing radiation therapy (RT) for prostate cancer (PCa).Technology Description:...
by TractManager | Sep 23, 2021 | Clinical Utility Evaluation
This report evaluates the clinical utility of cell-free DNA (cfDNA) (formerly NIPS, NIPT) screening for fetal sex chromosome aneuploidy (SCA) in women with singleton or twin pregnancies.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Sep 21, 2021 | Emerging Technology Report
Tivdak (tisotumab vedotin-tftv) is an intravenously administered tissue factor-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after...
Recent Comments